LPP2 mRNA (PLPP2) was 5.4, 8.1, and 8.2-fold higher in ER/PR positive, ER/HER2 positive, and triple negative breast cancer specimens, respectively, compared to normal breast tissue. This evidence concerns the gene PLPP2 and triple-negative breast carcinoma.